Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,579,261
-
Total 13F shares
-
2,226,005
-
Share change
-
-211,237
-
Total reported value
-
$38,335,000
-
Price per share
-
$17.19
-
Number of holders
-
46
-
Value change
-
-$3,729,087
-
Number of buys
-
19
-
Number of sells
-
22
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q2 2016
As of 30 Jun 2016,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,226,005 shares.
The largest 10 holders included
MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, LPL Financial LLC, UBS Group AG, BANK OF NOVA SCOTIA, Advisors Asset Management, Inc., STIFEL FINANCIAL CORP, FIRST TRUST ADVISORS LP, and LADENBURG THALMANN FINANCIAL SERVICES INC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.